NCT01300442

Brief Summary

Transcutaneous electrical diaphragmatic stimulation (TEDS) has been used to improve respiratory muscle strength in patients with respiratory muscles weakness. However, this physiotherapeutic resource has not been studied in chronic obstructive pulmonary disease (COPD) yet. The objective of this study is to evaluate the respiratory pattern during the session of TEDS besides its effect in respiratory muscle strength and in spirometric variables as much healthy patients as in COPD patients. Methods: healthy and COPD patients are selected and submitted to TEDS treatment. The plethysmographic analysis (LifeShirt System - VivoMetric), respiratory muscle strength and spirometry will be made. The hypothesis is that the TEDS can helps COPD patients that shows respiratory muscle weakness.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at P25-P50 for phase_1

Timeline
Completed

Started Feb 2011

Shorter than P25 for phase_1

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2011

Completed
17 days until next milestone

First Submitted

Initial submission to the registry

February 18, 2011

Completed
3 days until next milestone

First Posted

Study publicly available on registry

February 21, 2011

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2011

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2011

Completed
Last Updated

February 21, 2011

Status Verified

January 1, 2011

Enrollment Period

2 months

First QC Date

February 18, 2011

Last Update Submit

February 18, 2011

Conditions

Keywords

chronic obstructive pulmonary diseasediaphragmelectrical stimulationpulmonary rehabilitation

Outcome Measures

Primary Outcomes (1)

  • Respiratory muscle strength and spirometry

    Respiratory muscle strength: maximal inspiratory pressure (cH2O) and maximal expiratory pressure (cH2O) by manovacuometer (Gerar®) Spirometry by Spirometer EasyOne®

    06 weeks

Secondary Outcomes (1)

  • Respiratory pattern

    During the session of transcutaneous electrical diaphragmatic stimulation

Study Arms (2)

Control

EXPERIMENTAL

The transcutaneous electrical diaphragmatic stimulation will be applied in healthy and COPD subjects.

Other: TEDS in healthy patients

Chronic Obstructive Pulmonary Disease

EXPERIMENTAL

The intervention will be the TEDS in patients with Chronic Obstructive Pulmonary Disease (COPD)

Other: TEDS in COPD patients

Interventions

For the TEDS (transcutaneous electrical diaphragmatic stimulation) the electrical current is pulsed, biphasic and symmetric, with the following parameters: frequency of 30 Hertz; 0.4ms phase width, rise time of 0.7 seconds; respiratory rate of 14 rpm; intensity is the minimum necessary to obtain diaphragm muscle contraction. Four silicone-carbon electrodes (3x5cm) were placed on the skin with gel and micropore tape. Two electrodes were located on each side of the thorax, specifically in the 3rd intercostal space near the xyphoid region and in the 7th intercostal space, on the mid-axillary line. Each session had duration of approximately 30 minutes and the subjects were instructed to co-ordinate breathing with the pulsing of the electrical current.

Also known as: The equipment is the Dualpex 961 model Phrenics (Quark®).
Chronic Obstructive Pulmonary Disease

For the TEDS (transcutaneous electrical diaphragmatic stimulation) the electrical current is pulsed, biphasic and symmetric, with the following parameters: frequency of 30 Hertz; 0.4ms phase width, rise time of 0.7 seconds; respiratory rate of 14 rpm; intensity is the minimum necessary to obtain diaphragm muscle contraction. Four silicone-carbon electrodes (3x5cm) were placed on the skin with gel and micropore tape. Two electrodes were located on each side of the thorax, specifically in the 3rd intercostal space near the xyphoid region and in the 7th intercostal space, on the mid-axillary line. Each session had duration of approximately 30 minutes and the subjects were instructed to co-ordinate breathing with the pulsing of the electrical current.

Also known as: The equipment is the Dualpex 961 model Phrenics (Quark®).
Control

Eligibility Criteria

Age30 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with stable COPD (diagnosed by accepted criteria)
  • Healthy patients

You may not qualify if:

  • FOR THE COPD PATIENTS:
  • Over 80 years of age
  • History of recent exacerbation
  • Patients with pacemakers
  • Uncontrolled arterial hypertension
  • Requiring home oxygen therapy.
  • FOR THE HEALTHY PATIENTS:
  • Pulmonary diseases
  • Cardiovascular diseases
  • Orthopedic diseases
  • Neurologic diseases.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UFSCar

São Carlos, São Paulo, 13565-905, Brazil

RECRUITING

Related Publications (1)

  • Cancelliero-Gaiad KM, Ike D, Pantoni CB, Mendes RG, Borghi-Silva A, Costa D. Acute effects of transcutaneous electrical diaphragmatic stimulation on respiratory pattern in COPD patients: cross-sectional and comparative clinical trial. Braz J Phys Ther. 2013 Nov-Dec;17(6):547-55. doi: 10.1590/S1413-35552012005000121. Epub 2013 Nov 14.

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Dirceu Costa, PhD

    UFSCar

    STUDY DIRECTOR

Central Study Contacts

Dirceu Costa, PhD

CONTACT

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

February 18, 2011

First Posted

February 21, 2011

Study Start

February 1, 2011

Primary Completion

April 1, 2011

Study Completion

May 1, 2011

Last Updated

February 21, 2011

Record last verified: 2011-01

Locations